$7 million federal grant boosts Duke’s vaccine manufacturing initiative The Duke Human Vaccine Institute has been awarded a $7 million contract from the National Institute of Allergy and Infectious ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

Automation and artificial intelligence (AI) will be key to a new effort to manufacture millions of RNA vaccines in Africa, according to Cairo, Egypt-headquartered drug firm Eva Pharma. Eva Pharma made ...

The firm promises to produce millions of vaccine doses to in the case of an influenza pandemic.

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new vaccines has become crucial. However, the speed of vaccine production is ...

A clinical-grade recombinant virus-like particle (VLP) vaccine has been developed to prevent human parvovirus B19 (HPVB19) infection, which can have severe and potentially fatal complications in ...

Inside the rigorous, step-by-step process the CDC uses to create pandemic-ready flu vaccine viruses, long before the next global health emergency strikes. Study: Development of pre-pandemic influenza ...

On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans has already been developed and ...